The beat-to-beat decay of cardiac contractility from highly potentiated levels is bi-exponential

Mark I M Noble1, Per Arlock, Bjorn Wohlfart

  • 1Department of Cardiology, University of Aberdeen, UK. mimnoble@freenetname.co.uk

Journal of Biomechanics
|November 1, 2005
PubMed

Insights

Cardiac contractility decay deviates from simple models at high levels. A faster initial decay followed by a slower one, a bi-exponential pattern, was observed in ferret papillary muscle.

Area of Science:

  • Cardiology
  • Physiology
  • Biophysics

Background:

  • Cardiac contractility decay is typically modeled using mono-exponential functions.
  • This model assumes a fixed fraction of activator calcium ions are recirculated between heartbeats.
  • Deviations may occur at very high contractility levels.

Purpose of the Study:

  • To investigate the beat-to-beat decay of cardiac contractility following potentiation.
  • To determine if contractility decay deviates from mono-exponential models at high levels.

Main Methods:

  • Studied beat-by-beat decay of cardiac contractility in isolated ferret papillary muscle.
  • Utilized potentiation via prolonged depolarizations to achieve high contractility.
  • Employed single sucrose-gap voltage clamp techniques.
  • Analyzed decay curves using mono-exponential fitting and analysis of covariance.

Main Results:

  • A bi-exponential decay pattern was observed in 9 out of 11 muscles studied.
  • The initial decay phase was significantly faster than the subsequent slower phase.
  • The slower decay phase, within the physiological range, matched decay after post-extrasystolic potentiation.

Conclusions:

  • Cardiac contractility decay at high levels is better described by a bi-exponential model, not mono-exponential.
  • This suggests a more complex mechanism for calcium ion handling during potentiation.
  • The findings have implications for understanding cardiac function under stress.

Related Concept Videos

Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...